氯沙坦钾、美托洛尔与地高辛联用治疗扩张型心肌病心衰的临床探讨.docVIP

精品论文 参考文献 氯沙坦钾、美托洛尔与地高辛联用治疗扩张型心肌病心衰的临床探讨 （滨海县人民医院心内科 江苏盐城 224500） 【摘要】目的：探讨氯沙坦钾、美托洛尔与地高辛联用在扩张型心肌病心衰临床中的应用价值。方法：选取在我院接诊的47例扩张型心肌病心衰患者，其接受氯沙坦钾、美托洛尔与地高辛联用治疗，设为观察组。回顾性分析同期在我院接诊的47例扩张型心肌病心衰患者的临床资料，其接受常规治疗，设为对照组。结果：在接受不同治疗情况下，两组扩张型心肌病心衰患者的临床疗效对比，差异明显，具有统计学意义（P＜0.05）；两组扩张型心肌病心衰患者不良反应对比，差异明显，具有统计学意义（P＜0.05）。结论：氯沙坦钾、美托洛尔与地高辛联用治疗能够改善扩张型心肌病心衰患者的心肌功能，疗效显著。 【关键词】氯沙坦钾；美托洛尔；地高辛；扩张型心肌病；心衰 Losartan potassium, metoprolol and digoxin associated clinical investigate the treatment of dilated cardiomyopathy with heart failure 【Abstract】Objective:Discussion losartan potassium, metoprolol and digoxin in combination with applications in dilated heart failure clinic..Methods:Select admissions in our hospital 47 cases of dilated cardiomyopathy patients with heart failure, their acceptance losartan potassium, metoprolol and digoxin in combination with treatment, observation group. Retrospective analysis of clinical data of the same period in admissions of 47 cases of dilated cardiomyopathy patients with heart failure, which received conventional treatment, to the control group.Results:Receive different treatment in the case of comparing the clinical efficacy of two groups of heart failure patients with dilated cardiomyopathy, the differences are significant, statistically significant (P lt;0.05); two patients with dilated cardiomyopathy with heart failure adverse reactions contrast, differences are significant, statistically significant (P lt;0.05).Conclusion:Losartan potassium, metoprolol and digoxin in combination with therapy can improve cardiac function in dilated cardiomyopathy patients with heart failure, a significant effect. 【Key words】Losartan potassium; metoprolol; digoxin; dilated cardiomyopathy; heart failure 扩张型心肌病属于临床中常见的心脏疾病之一，其中心衰是表现的并发症表现，扩张型心肌病顽固性心衰具有较高的病死率和致残率，严重威胁患者的生命健康[1]。本组试验主要对氯沙坦钾、美托洛尔与地高辛联用治疗扩张型心肌病顽固性心衰的疗效进行研究，具体研究报告如下[2]。需要不断提高扩张型心肌病心衰的临床治疗效果，改善患者的生活质量，现进行如下报道。 1 资料与方法 1.1 临床资料 选取2013年11月至2015年5月期间，在我院接诊的47例扩张型心肌病心衰患者，设为观察组。回顾性分析同期在我院接诊的47